tiprankstipranks
Trellus Health PLC (GB:TRLS)
LSE:TRLS

Trellus Health PLC (TRLS) Share Price & Analysis

2 Followers

TRLS Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1.50p - 9.65p
Previous Close1.75p
Volume106.70K
Average Volume (3M)272.62K
Market Cap
£2.83M
Enterprise Value-12.52M
Total Cash (Recent Filing)$19.09M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.5
Beta-0.18
Apr 23, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume272,615
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-695.71
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%0.00%100.00%
0.00%
Insiders
0.00% Other Institutional Investors
100.00% Public Companies and
Individual Investors

TRLS FAQ

What was Trellus Health PLC’s price range in the past 12 months?
Trellus Health PLC lowest share price was 1.50p and its highest was 9.65p in the past 12 months.
    What is Trellus Health PLC’s market cap?
    Currently, no data Available
    When is Trellus Health PLC’s upcoming earnings report date?
    Trellus Health PLC’s upcoming earnings report date is Apr 23, 2024 which is 5 days ago.
      How were Trellus Health PLC’s earnings last quarter?
      Trellus Health PLC released its earnings results on Sep 28, 2023. The company reported -0.016p earnings per share for the quarter, missing the consensus estimate of N/A by -0.016p.
        Is Trellus Health PLC overvalued?
        According to Wall Street analysts Trellus Health PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Trellus Health PLC pay dividends?
          Trellus Health PLC does not currently pay dividends.
          What is Trellus Health PLC’s EPS estimate?
          Trellus Health PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Trellus Health PLC have?
          Trellus Health PLC has 161,508,330 shares outstanding.
            What happened to Trellus Health PLC’s price movement after its last earnings report?
            Trellus Health PLC reported an EPS of -0.016p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.824%.
              Which hedge fund is a major shareholder of Trellus Health PLC?
              Currently, no hedge funds are holding shares in GB:TRLS
              ---

              Company Description

              Trellus Health PLC

              Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care remotely via telehealth. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              ANGLE plc
              EKF Diagnostics Holdings
              Genedrive
              Inspiration Healthcare
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis